Viewing StudyNCT00046254



Ignite Creation Date: 2024-05-05 @ 11:26 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00046254
Status: COMPLETED
Last Update Posted: 2012-05-02
First Post: 2002-09-24

Brief Title: Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Hip Fracture
Osteoporosis
Keywords:
Name View
orthopedic View
hip fracture View
recurrent fracture View
fracture View
bone loss View
bisphosphonate View
bone mineral density View
osteoporosis View
zoledronic acid View
geriatrics View
rehabilitation View
elderly View
nursing home View